Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis

Clin Vaccine Immunol. 2009 Mar;16(3):430-2. doi: 10.1128/CVI.00480-08. Epub 2009 Jan 14.

Abstract

We report on the efficacy of the genetically engineered Candida albicans tet-NRG1 strain as an experimental live, attenuated vaccine against disseminated candidiasis in both immunocompetent and immunodeficient mice mostly dependent on T-cell immunity. This experimental vaccination model may represent an important tool to unravel the mechanisms of protective immunity during candidiasis.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Candida albicans / genetics
  • Candida albicans / immunology*
  • Candidiasis / immunology
  • Candidiasis / prevention & control*
  • Fungal Vaccines / genetics
  • Fungal Vaccines / immunology*
  • Mice
  • Neuregulin-1 / genetics
  • Neuregulin-1 / immunology*
  • Survival Analysis
  • T-Lymphocytes / immunology
  • Vaccines, Attenuated / genetics
  • Vaccines, Attenuated / immunology
  • Vaccines, Synthetic / genetics
  • Vaccines, Synthetic / immunology

Substances

  • Fungal Vaccines
  • Neuregulin-1
  • Vaccines, Attenuated
  • Vaccines, Synthetic